Krenning EP - Search Results

1

86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion.

Jamar F, Barone R, Mathieu I, Walrand S, Labar D, Carlier P, de Camps J, Schran H, Chen T, Smith MC, Bouterfa H, Valkema R, Krenning EP, Kvols LK, Pauwels S. Jamar F, et al. Among authors: krenning ep. Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):510-8. doi: 10.1007/s00259-003-1117-1. Epub 2003 Feb 12. Eur J Nucl Med Mol Imaging. 2003. PMID: 12582815 Clinical Trial.

2

Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?

Walrand S, Flux GD, Konijnenberg MW, Valkema R, Krenning EP, Lhommel R, Pauwels S, Jamar F. Walrand S, et al. Among authors: krenning ep. Eur J Nucl Med Mol Imaging. 2011 May;38 Suppl 1:S57-68. doi: 10.1007/s00259-011-1771-7. Epub 2011 Mar 11. Eur J Nucl Med Mol Imaging. 2011. PMID: 21484382 Review.

3

Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine.

Rolleman EJ, Valkema R, de Jong M, Kooij PP, Krenning EP. Rolleman EJ, et al. Among authors: krenning ep. Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):9-15. doi: 10.1007/s00259-002-0982-3. Epub 2002 Oct 29. Eur J Nucl Med Mol Imaging. 2003. PMID: 12483404 Clinical Trial.

4

Metabolic effects of amino acid solutions infused for renal protection during therapy with radiolabelled somatostatin analogues.

Barone R, Pauwels S, De Camps J, Krenning EP, Kvols LK, Smith MC, Bouterfa H, Devuyst O, Jamar F. Barone R, et al. Among authors: krenning ep. Nephrol Dial Transplant. 2004 Sep;19(9):2275-81. doi: 10.1093/ndt/gfh362. Epub 2004 Jul 13. Nephrol Dial Transplant. 2004. PMID: 15252161

5

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship.

Barone R, Borson-Chazot F, Valkema R, Walrand S, Chauvin F, Gogou L, Kvols LK, Krenning EP, Jamar F, Pauwels S. Barone R, et al. Among authors: krenning ep. J Nucl Med. 2005 Jan;46 Suppl 1:99S-106S. J Nucl Med. 2005. PMID: 15653658 Free article. Clinical Trial.

6

Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors.

Valkema R, Pauwels S, Kvols LK, Barone R, Jamar F, Bakker WH, Kwekkeboom DJ, Bouterfa H, Krenning EP. Valkema R, et al. Among authors: krenning ep. Semin Nucl Med. 2006 Apr;36(2):147-56. doi: 10.1053/j.semnuclmed.2006.01.001. Semin Nucl Med. 2006. PMID: 16517236 Clinical Trial.

7

Therapy using labelled somatostatin analogues: comparison of the absorbed doses with 111In-DTPA-D-Phe1-octreotide and yttrium-labelled DOTA-D-Phe1-Tyr3-octreotide.

Barone R, Walrand S, Konijnenberg M, Valkema R, Kvols LK, Krenning EP, Pauwels S, Jamar F. Barone R, et al. Among authors: krenning ep. Nucl Med Commun. 2008 Mar;29(3):283-90. doi: 10.1097/MNM.0b013e3282f3d03e. Nucl Med Commun. 2008. PMID: 18349800 Clinical Trial.

8

Megalin is essential for renal proximal tubule reabsorption of (111)In-DTPA-octreotide.

de Jong M, Barone R, Krenning E, Bernard B, Melis M, Visser T, Gekle M, Willnow TE, Walrand S, Jamar F, Pauwels S. de Jong M, et al. J Nucl Med. 2005 Oct;46(10):1696-700. J Nucl Med. 2005. PMID: 16204720 Free article.

9

Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues.

Rolleman EJ, Melis M, Valkema R, Boerman OC, Krenning EP, de Jong M. Rolleman EJ, et al. Among authors: krenning ep. Eur J Nucl Med Mol Imaging. 2010 May;37(5):1018-31. doi: 10.1007/s00259-009-1282-y. Epub 2009 Nov 14. Eur J Nucl Med Mol Imaging. 2010. PMID: 19915842 Review.

10

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.

De Jong M, Valkema R, Jamar F, Kvols LK, Kwekkeboom DJ, Breeman WA, Bakker WH, Smith C, Pauwels S, Krenning EP. De Jong M, et al. Among authors: krenning ep. Semin Nucl Med. 2002 Apr;32(2):133-40. doi: 10.1053/snuc.2002.31027. Semin Nucl Med. 2002. PMID: 11965608 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

461 results

Search Page